Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Other financing activities (2022 - 2024)

Historic Other financing activities for Indivior Pharmaceuticals (INDV) over the last 1 years, with Q1 2024 value amounting to -$1.0 million.

  • Indivior Pharmaceuticals' Other financing activities changed N/A to -$1.0 million in Q1 2024 from the same period last year, while for Jun 2025 it was -$1.0 million, marking a year-over-year change of. This contributed to the annual value of -$2.0 million for FY2024, which is N/A changed from last year.
  • Per Indivior Pharmaceuticals' latest filing, its Other financing activities stood at -$1.0 million for Q1 2024.
  • Indivior Pharmaceuticals' Other financing activities' 5-year high stood at -$1.0 million during Q1 2024, with a 5-year trough of -$1.0 million in Q1 2024.